Transplantation Technologies & Research

Rodney Davis

Publications

• Review Article
  Intravesicle Bacillus Calmette–Guérin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC) in the Transplanted Patients Population: A Systematic Review of the World Literature
  Author(s): Omer A Raheem, Rodney Davis, Ehab A Eltahawy and Mohamed H. KamelOmer A Raheem, Rodney Davis, Ehab A Eltahawy and Mohamed H. Kamel
  
  Intravesicle Bacille Calmette-Guerin (BCG) is generally considered to be contraindicated in the immunosuppressed or compromised patients with bladder cancer (BC) because of ineffectiveness or partial toxicities. Therefore, there is little experience with BCG in individual with impaired immune system and this can be challenging to practicing urologists. We sought to review the current available evidence of utilizing intravesicle BCG for BC in patients with solid organ transplantation and commented on its current status... Read More»
  DOI: 10.4172/2161-0991.1000144

  Abstract PDF